omega-N-Allylarginine






33 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 14565611 Socio-economic and health characteristics of HIV-infected patients seeking care in relation to access to the Drug Access Initiative and to antiretroviral treatment in Côte d'Ivoire. AIDS 2003 Jul 1
2 18395383 [Demographic, clinical, immunovirological and therapeutic features of 8714 HIV infected French patients included in the Nadis Hospital Cohorte in 2006]. Med Mal Infect 2008 Jun 1
3 19168198 Modulation of p53 by mitogen-activated protein kinase pathways and protein kinase C delta during avian reovirus S1133-induced apoptosis. Virology 2009 Mar 15 1
4 19431223 Clinical and microbiological assessment of patients with a long-term diagnosis of human immunodeficiency virus infection and Candida oral colonization. Clin Microbiol Infect 2009 Apr 1
5 19560381 Evaluation of IGF-2/ApaI polymorphism in pregnant women infected with human immunodeficiency virus type 1 taking antiretroviral drugs. Growth Horm IGF Res 2009 Dec 1
6 20182359 Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV. J Acquir Immune Defic Syndr 2010 May 1 2
7 23049663 Auditing national HIV guidelines and policies: The United Kingdom CD4 Surveillance Scheme. Open AIDS J 2012 1
8 23298916 Haplotypes frequencies of CYP2B6 in Malaysia. J Postgrad Med 2012 Oct-Dec 1
9 26223347 Relationship between blood pressure variability and renal activity of the renin-angiotensin system. J Hum Hypertens 2016 May 2
10 26441882 Role of MRP transporters in regulating antimicrobial drug inefficacy and oxidative stress-induced pathogenesis during HIV-1 and TB infections. Front Microbiol 2015 1
11 26558396 HIV Drug Resistance Surveillance in Honduras after a Decade of Widespread Antiretroviral Therapy. PLoS One 2015 1
12 28370504 CYP1A1m1 and CYP2C9*2 and *3 polymorphism and risk to develop ARV-associated hepatotoxicity and its severity. APMIS 2017 Jun 8
13 28754673 Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer Irradiation. Cancer Res 2017 Sep 15 1
14 29476044 Antiretroviral Drug Metabolism in Humanized PXR-CAR-CYP3A-NOG Mice. J Pharmacol Exp Ther 2018 May 1
15 29764864 Targeting the Hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant Prostate Cancer. Cancer Res 2018 Jul 15 1
16 29849489 IL-1RN and IL-1<i>β</i> Polymorphism and ARV-Associated Hepatotoxicity. Mediators Inflamm 2018 2
17 29864532 Occurrence of APOBEC3G variations in West Indian HIV patients. Microb Pathog 2018 Aug 1
18 29927129 [Evaluation of antiretroviral treatment in HIV infected adult in the department of dermatology venereology of the Donka national hospital]. Mali Med 2015 1
19 30606790 Proteolysis targeting chimeric molecules as therapy for multiple myeloma: efficacy, biomarker and drug combinations. Haematologica 2019 Jun 2
20 30864294 Occurrence of CYP2B6 516G&gt;T polymorphism in patients with ARV-associated hepatotoxicity. Mol Genet Genomic Med 2019 Apr 1
21 30973108 Occurrence of Interleukin-2 (330 G/T) Promoter Polymorphism in ARV associated hepatotoxicity. Curr Mol Med 2019 1
22 31121270 Interleukin-10 polymorphisms and susceptibility to ARV associated hepatotoxicity. Microb Pathog 2019 Aug 1
23 31315987 Differential Dynamics of Regulatory T-Cell and Th17 Cell Balance in Mesenteric Lymph Nodes and Blood following Early Antiretroviral Initiation during Acute Simian Immunodeficiency Virus Infection. J Virol 2019 Oct 1 1
24 31394259 BRD4 PROTAC as a novel therapeutic approach for the treatment of vemurafenib resistant melanoma: Preformulation studies, formulation development and in vitro evaluation. Eur J Pharm Sci 2019 Oct 1 1
25 31762906 Differential expression of Fas receptors (CD95) and Fas ligands (CD95L) in HIV infected and exposed uninfected children in Cameroon versus unexposed children. Pan Afr Med J 2019 2
26 32516289 Ambulatory blood pressure variability and risk of cardiovascular events, all-cause mortality, and progression of kidney disease. J Hypertens 2020 Sep 1
27 32559187 Multiple myeloma: Combination therapy of BET proteolysis targeting chimeric molecule with CDK9 inhibitor. PLoS One 2020 3
28 32626742 Chitosan-Based Delivery of Avian Reovirus Fusogenic Protein p10 Gene: <i>In Vitro</i> and <i>In Vivo</i> Studies towards a New Vaccine against Melanoma. Biomed Res Int 2020 1
29 33324552 PROTAC Bromodomain Inhibitor ARV-825 Displays Anti-Tumor Activity in Neuroblastoma by Repressing Expression of <i>MYCN</i> or <i>c-Myc</i>. Front Oncol 2020 4
30 33888130 BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes. Cancer Cell Int 2021 Apr 22 6
31 34656700 KDR polymorphism (1192G/A, 1719A/T) and modulation of ARV drug-induced hepatotoxicity. Microb Pathog 2021 Dec 1
32 34733788 ARV-825 Demonstrates Antitumor Activity in Gastric Cancer <i>via</i> MYC-Targets and G2M-Checkpoint Signaling Pathways. Front Oncol 2021 2
33 35146591 Susceptibility of Lung Carcinoma Cells to Nanostructured Lipid Carrier of ARV-825, a BRD4 Degrading Proteolysis Targeting Chimera. Pharm Res 2022 Feb 10 1